123 related articles for article (PubMed ID: 2846843)
1. Phenotypic expression of natural killer cell associated membrane antigens in patients with chronic liver disease and hepatocellular carcinoma.
Kakumu S; Hirofuji H; Fuji A; Tahara H; Yoshioka K
J Clin Lab Immunol; 1988 May; 26(1):29-32. PubMed ID: 2846843
[TBL] [Abstract][Full Text] [Related]
2. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic expression of natural killer cell associated membrane antigens and cytolytic function of peripheral blood cells from different aged humans.
Bender BS; Chrest FJ; Adler WH
J Clin Lab Immunol; 1986 Sep; 21(1):31-6. PubMed ID: 3100806
[TBL] [Abstract][Full Text] [Related]
4. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF
J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
Attallah AM; Tabll AA; El-Sadany M; Ibrahim TA; El-Dosoky I
Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
[TBL] [Abstract][Full Text] [Related]
6. [Hepatocarcinoma and killer cell activity].
Lucea D; Vargas V; Español T; Castells L; Sauleda S; Esteban R; Guardia J
Med Clin (Barc); 1995 Sep; 105(10):370-3. PubMed ID: 7475439
[TBL] [Abstract][Full Text] [Related]
7. Depressed lymphokine-activated killer activity and analysis of the precursor cells in peripheral blood of patients with hepatocellular carcinoma.
Shirai M; Watanabe S; Nishioka M
Hepatogastroenterology; 1990 Oct; 37(5):465-8. PubMed ID: 2174825
[TBL] [Abstract][Full Text] [Related]
8. [Natural killer cell activity of the peripheral blood in patients with hepatocellular carcinoma].
Lin ZY; Weng HZ; Tang ZY; Wang QD
Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):417-20. PubMed ID: 2438105
[TBL] [Abstract][Full Text] [Related]
9. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
Ishiyama K; Ohdan H; Ohira M; Mitsuta H; Arihiro K; Asahara T
Hepatology; 2006 Feb; 43(2):362-72. PubMed ID: 16440347
[TBL] [Abstract][Full Text] [Related]
10. Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver.
Nakajima T; Mizushima N; Kanai K
Jpn J Clin Oncol; 1987 Dec; 17(4):327-32. PubMed ID: 2826847
[TBL] [Abstract][Full Text] [Related]
11. [NK activity in various liver diseases--especially the relation between NK activity and reserve function of the liver in liver cirrhosis and hepatocellular carcinoma].
Takagi H; Sakurai S; Uehara M; Yamada S; Kobayashi S
Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2369-74. PubMed ID: 2559127
[TBL] [Abstract][Full Text] [Related]
12. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.
Ohira M; Ohdan H; Mitsuta H; Ishiyama K; Tanaka Y; Igarashi Y; Asahara T
Transplantation; 2006 Dec; 82(12):1712-9. PubMed ID: 17198265
[TBL] [Abstract][Full Text] [Related]
13. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.
Cai L; Zhang Z; Zhou L; Wang H; Fu J; Zhang S; Shi M; Zhang H; Yang Y; Wu H; Tien P; Wang FS
Clin Immunol; 2008 Dec; 129(3):428-37. PubMed ID: 18824414
[TBL] [Abstract][Full Text] [Related]
14. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
[TBL] [Abstract][Full Text] [Related]
15. [Identification of immunological effector cells after autologous cytokine-induced killer cells treatment and its clinical implication in hepatocellular carcinoma patients].
Shi M; Zhang B; Tang ZR; Lei ZY; Wang HF; Feng YY; Liu JC; Fan ZP; Li HW; Mu JS; Wang FS
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2049-53. PubMed ID: 14703414
[TBL] [Abstract][Full Text] [Related]
16. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.
Jinushi M; Takehara T; Tatsumi T; Hiramatsu N; Sakamori R; Yamaguchi S; Hayashi N
J Hepatol; 2005 Dec; 43(6):1013-20. PubMed ID: 16168521
[TBL] [Abstract][Full Text] [Related]
17. Expression of inhibitory receptors in natural killer (CD3(-)CD56(+)) cells and CD3(+)CD56(+) cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma.
Yuen MF; Norris S
Clin Immunol; 2001 Dec; 101(3):264-9. PubMed ID: 11726217
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cells in Behçet's disease.
Hamzaoui K; Ayed K; Hamza M; Touraine JL
Clin Exp Immunol; 1988 Jan; 71(1):126-31. PubMed ID: 3258201
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells in peripheral blood after autologous bone marrow transplantation: a combined phenotypic and functional study.
Jorgensen H; Hokland P; Jensen T; Basse P; Hokland M
Nat Immun; 1995; 14(3):164-72. PubMed ID: 8832900
[TBL] [Abstract][Full Text] [Related]
20. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]